Purchase Order HHSN261201700010A
Award Date 3/20/17
Potential Completion Date 3/8/23
Potential Value $113K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Illumina, Inc. for $12,081.90. The contract is not designated as a set-aside. Illumina, a manufacturer of genetic sequencing equipment and supplies, will provide goods and services to support genomic sequencing and analysis for research and diagnostics purposes. The award is likely part of a larger Indefinite...
- This is a firm fixed price delivery order awarded by the National Cancer Institute (NCI), a civilian agency under the U.S. Department of Health and Human Services, to Illumina, Inc. for the provision of biological kits. The order has a ceiling value of $45,077.60 and a period of performance through April 30, 2025. Illumina, a manufacturer of sequencing and genomic analysis products, has previously received prime federal contracts and subcontracts from agencies like NIH, CDC, USDA, and VA to...
- This is a firm fixed-price delivery order awarded by the National Cancer Institute, a civilian agency under the Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The $24,230.96 contract provides Illumina sequencing systems, reagents, and services to support genomic research and diagnostics. The award is not associated with a set-aside program. Through past prime contract and subcontract awards, Illumina has...
- This is a firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis equipment. The contract provides for an equipment maintenance agreement on Illumina sequencing systems, such as NextSeq, NovaSeq, MiSeq, and iSeq models, with a ceiling value of $16,198.00 and a performance period ending on December 4, 2025. The contract does...
- This is a firm fixed price delivery order awarded by the National Cancer Institute, a civilian agency of the U.S. government, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The $26,800.70 award is for the provision of biological kits, Illumina sequencing equipment, and associated services. Illumina has been a frequent supplier of sequencing technology and expertise to federal agencies like the NIH, CDC, USDA, and VA. This award does not utilize any set-aside...
- This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for a one-year comprehensive plan to provide HiSeq 2000, cBOT, and MiSeq systems. The $100,884 contract does not include a set-aside provision. Illumina is a manufacturer of genetic sequencing and analysis instruments and reagents that have been utilized across various federal agencies, including the Centers...
- This is a firm fixed-price Delivery Order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $38,027.60 award is for the provision of lab supplies, specifically Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, and consumables. This Delivery Order is likely part of a larger Indefinite...
- This is a $263,862.50 firm fixed price purchase order awarded by the National Cancer Institute (NCI), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the procurement of laboratory equipment and supplies, specifically various Illumina sequencing systems, reagents, and consumables to support the NCI Surgery Branch's genetic sequencing needs. The award does not have a set-aside designation. Illumina has previously received other prime federal...
- This is a firm fixed price delivery order awarded by the National Cancer Institute, an agency of the U.S. Department of Health and Human Services, to Illumina, Inc. for $3,689.79. Illumina, a manufacturer of genome sequencing and analysis instruments and reagents, will provide its proprietary sequencing systems, consumables, and support services to the agency. This order is part of a larger Indefinite Delivery Contract worth up to $3.3 million that Illumina holds with the Department of the...
- This is a firm fixed price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomics sequencing and analysis solutions. The contract, valued at $15,388.08, is for the provision of sequencing systems, reagents, and services to support genomic research and diagnostics. Illumina has a history of providing similar products and services to various federal agencies, including the NIH, CDC, USDA, and VA, under...